Company Filing History:
Years Active: 2013-2017
Title: Erica Brook Goodhew: Innovator in Cell Migration Control
Introduction
Erica Brook Goodhew is a prominent inventor based in Atlanta, GA (US). She has made significant contributions to the field of cell migration control, focusing on the development of innovative methods and compositions that influence the movement of cells. With a total of 2 patents, her work is paving the way for advancements in medical treatments related to immune, inflammatory, and cancerous conditions.
Latest Patents
Goodhew's latest patents include groundbreaking inventions. The first patent, titled "Chemorepulsion of cells," provides compositions and methods for controlling the direction and movement of migratory cells. This invention identifies novel chemorepellents and unimodal fugetaxins, along with their agonists and antagonists, which can alter the movement of cells involved in various health conditions. The second patent, "Method of inducing negative chemotaxis," outlines methods for inducing negative chemotaxis in migratory cells. This involves contacting the cells with specific compounds, including idebenone, benazepril, and Vitamin D analogs, among others.
Career Highlights
Goodhew is currently associated with Celtaxsys, Inc., where she continues to innovate and develop her research. Her work is instrumental in advancing the understanding of cell behavior and its implications for health and disease.
Collaborations
Throughout her career, Goodhew has collaborated with notable colleagues, including Hyun Kang and Scott Sacane. These partnerships have contributed to her success and the impact of her inventions.
Conclusion
Erica Brook Goodhew is a trailblazer in the field of cell migration control, with her patents offering promising solutions for medical challenges. Her dedication to innovation and collaboration continues to drive advancements in this critical area of research.